Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    21334595 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)
Condition: Type 2 Idiopathic Macular Telangiectasia
Intervention: Drug: Intravitreal injection ranibizumab

Study has passed its completion date and status has not been verified in more than two years.